Taurocholic Acid in EAE Model
Corresponding Organization : University of Virginia
Variable analysis
- Taurocholic acid (100 μL of 125 mg/mL in saline) or saline (100 μL)
- Gavage administration of taurocholic acid or saline
- Mice were monitored and scored as described earlier
- Female and male C57BL6/J mice
- Immunization with MOG
- Gavage administration started on day 4 and continued through day 10
- Positive control: Taurocholic acid (125 mg/mL in saline)
- Negative control: Saline
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!